Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid Program
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 8 (4) , 495-505
- https://doi.org/10.1111/j.1524-4733.2005.00041.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- PUR5: THE IMPACT OF PHARMACOTHERAPY ON OVERACTIVE BLADDER SYMPTOM IMPROVEMENT AND RESOURCE UTILIZATIONValue in Health, 2001
- PUR3: PERSISTENCE OF THERAPY WITH DRUGS FOR OVERACTIVE BLADDERValue in Health, 2001
- Twelve-Month Treatment of Overactive BladderDrugs & Aging, 2001
- Predictors of Long-term Persistence on Statins in a Subsidized Clinical PopulationValue in Health, 2000
- Incontinence Drug Utilization Patterns in Québec, CanadaValue in Health, 1999
- An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladderClinical Therapeutics, 1999
- Patient Decision Making: The Missing Ingredient in Compliance ResearchInternational Journal of Technology Assessment in Health Care, 1995
- Backward, forward and stepwise automated subset selection algorithms: Frequency of obtaining authentic and noise variablesBritish Journal of Mathematical and Statistical Psychology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Comparison of Stopping Rules in Forward Stepwise Discriminant AnalysisJournal of the American Statistical Association, 1979